Cargando…

Projected Number of People With Onchocerciasis–Loiasis Coinfection in Africa, 1995 to 2025

BACKGROUND: Onchocerciasis elimination through mass drug administration (MDA) is hampered by coendemicity of Loa loa, as people with high L. loa microfilariae (mf) density can develop serious adverse events (SAEs) after ivermectin treatment. We assessed the geographical overlap of onchocerciasis and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vinkeles Melchers, Natalie V S, Coffeng, Luc E, Boussinesq, Michel, Pedrique, Belén, Pion, Sébastien D S, Tekle, Afework H, Zouré, Honorat G M, Wanji, Samuel, Remme, Jan H, Stolk, Wilma A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Articles and Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245158/ https://www.ncbi.nlm.nih.gov/pubmed/31304961 http://dx.doi.org/10.1093/cid/ciz647

Ejemplares similares

Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results
por: Tekle, Afework H., et al.
Publicado: (2016)

The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030
por: Vinkeles Melchers, Natalie V. S., et al.
Publicado: (2021)

The Geographic Distribution of Loa loa in Africa: Results of Large-Scale Implementation of the Rapid Assessment Procedure for Loiasis (RAPLOA)
por: Zouré, Honorat Gustave Marie, et al.
Publicado: (2011)

How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?
por: Vinkeles Melchers, Natalie V. S., et al.
Publicado: (2021)

The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (1) priority areas for ivermectin treatment
por: Noma, Mounkaila, et al.
Publicado: (2014)

African Program for Onchocerciasis Control 1995–2010: Impact of Annual Ivermectin Mass Treatment on Off-Target Infectious Diseases
por: Krotneva, Stanimira P., et al.
Publicado: (2015)

The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (2) pre-control endemicity levels and estimated number infected
por: Zouré, Honorat GM, et al.
Publicado: (2014)

How Can Onchocerciasis Elimination in Africa Be Accelerated? Modeling the Impact of Increased Ivermectin Treatment Frequency and Complementary Vector Control
por: Verver, Suzanne, et al.
Publicado: (2018)

Impact of repeated ivermectin treatments against onchocerciasis on the transmission of loiasis: an entomologic evaluation in central Cameroon
por: Kouam, Marc K, et al.
Publicado: (2013)

African Programme for Onchocerciasis Control 1995–2015: Model-Estimated Health Impact and Cost
por: Coffeng, Luc E., et al.
Publicado: (2013)

African Programme for Onchocerciasis Control 1995–2015: Updated Health Impact Estimates Based on New Disability Weights
por: Coffeng, Luc E., et al.
Publicado: (2014)

Onchocerciasis-associated epilepsy in Maridi, South Sudan: Modelling and exploring the impact of control measures against river blindness
por: Bhattacharyya, Samit, et al.
Publicado: (2023)

Elimination of onchocerciasis in Africa by 2025: an ambitious target requires ambitious interventions
por: Colebunders, Robert, et al.
Publicado: (2019)

Burden of onchocerciasis-associated epilepsy: first estimates and research priorities
por: Vinkeles Melchers, Natalie V. S., et al.
Publicado: (2018)

Onchocerciasis: The Pre-control Association between Prevalence of Palpable Nodules and Skin Microfilariae
por: Coffeng, Luc E., et al.
Publicado: (2013)

Community-directed delivery of doxycycline for the treatment of onchocerciasis in areas of co-endemicity with loiasis in Cameroon
por: Wanji, Samuel, et al.
Publicado: (2009)

Combined Utilisation of Rapid Assessment Procedures for Loiasis (RAPLOA) and Onchocerciasis (REA) in Rain forest Villages of Cameroon
por: Wanji, Samuel, et al.
Publicado: (2005)

Standardisation of lymphatic filariasis microfilaraemia prevalence estimates based on different diagnostic methods: a systematic review and meta-analysis
por: Vinkeles Melchers, Natalie V. S., et al.
Publicado: (2020)

Model-Based Geostatistical Mapping of the Prevalence of Onchocerca volvulus in West Africa
por: O’Hanlon, Simon J., et al.
Publicado: (2016)

Report of the first international workshop on onchocerciasis-associated epilepsy
por: Colebunders, Robert, et al.
Publicado: (2018)

Atypical Clinical Manifestations of Loiasis and Their Relevance for Endemic Populations
por: Buell, Kevin G, et al.
Publicado: (2019)

Pulmonary Loiasis and HIV Coinfection in Rural Cameroon
por: Cambanis, Alexis
Publicado: (2010)

Co-endemicity of Loiasis and Onchocerciasis in Rain Forest Communities in Southwestern Nigeria
por: Ojurongbe, Olusola, et al.
Publicado: (2015)

Development and validation of small animal models for onchocerciasis and loiasis microfilaricide discovery
por: Ayiseh, Rene Bilingwe, et al.
Publicado: (2023)

Validation of the rapid assessment procedure for loiasis (RAPLOA) in the democratic republic of Congo
por: Wanji, Samuel, et al.
Publicado: (2012)

Performance of two serodiagnostic tests for loiasis in a Non-Endemic area
por: Gobbi, Federico, et al.
Publicado: (2020)

Safety and Efficacy of Levamisole in Loiasis: A Randomized, Placebo-controlled, Double-blind Clinical Trial
por: Campillo, Jérémy T, et al.
Publicado: (2021)

An Integrated District Mapping Strategy for Loiasis to Enable Safe Mass Treatment for Onchocerciasis in Gabon
por: Ella, Sylvie Ntsame, et al.
Publicado: (2022)

Case-control Studies on the Relationship between Onchocerciasis and Epilepsy: Systematic Review and Meta-analysis
por: Kaiser, Christoph, et al.
Publicado: (2013)

The impact of mass drug administration expansion to low onchocerciasis prevalence settings in case of connected villages
por: de Vos, Anneke S., et al.
Publicado: (2021)

Mapping the distribution of Loa loa in Cameroon in support of the African Programme for Onchocerciasis Control
por: Thomson, Madeleine C, et al.
Publicado: (2004)

Elimination of onchocerciasis in Africa by 2025: the need for a broad perspective
por: Cupp, Ed, et al.
Publicado: (2019)

“Test and not treat” for onchocerciasis control in a Loa loa endemic area
por: Kamgno, Joseph, et al.
Publicado: (2017)

Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control
por: Tekle, Afework Hailemariam, et al.
Publicado: (2012)

Sociodemographics, Clinical Factors, and Biological Factors Associated with Loiasis in Endemic Onchocerciasis Areas in Southern Gabon
por: Moutongo Mouandza, Reinne, et al.
Publicado: (2023)

Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis
por: Stolk, Wilma A., et al.
Publicado: (2015)

The effect of assortative mixing on stability of low helminth transmission levels and on the impact of mass drug administration: Model explorations for onchocerciasis
por: de Vos, Anneke S., et al.
Publicado: (2018)

Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns
por: Cano, Jorge, et al.
Publicado: (2018)

Elimination of African Onchocerciasis: Modeling the Impact of Increasing the Frequency of Ivermectin Mass Treatment
por: Coffeng, Luc E., et al.
Publicado: (2014)

Onchocerciasis: shifting the target from control to elimination requires a new first-step—elimination mapping
por: Rebollo, Maria P, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lmv9rucsqvlglp69k1g90e1o69